Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 137281000087117 | Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 21551000087114 | HB Engerix B pediatric GSK | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 21571000087115 | Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 73811000087113 | HB Engerix B pédiatrique GSK | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Pediatric vaccine product containing only Hepatitis B virus low strength antigen (medicinal product) | true | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis B virus recombinant surface antigen | true | Inferred relationship | Some | 1 | |
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient characteristic (attribute) | faible dose | false | Inferred relationship | Some | 1 | |
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has product characteristic | enfance | false | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Hepatitis B virus vaccine (substance) | false | Inferred relationship | Some | 1 | |
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has target population | Pediatric population (qualifier value) | true | Inferred relationship | Some | ||
| Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has ingredient qualitative strength | faible dose | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR